SOURCE: Cell Bio-Systems

August 18, 2005 12:21 ET

Cell Bio-Systems Announces Tulip Brand Line of Products for the Plastic Surgery Market

SAN DIEGO, CA -- (MARKET WIRE) -- August 18, 2005 --Cell Bio-Systems, Inc. (OTC: CBSI) is pleased to announce the decision to use the Tulip brand name in its Plastic Surgery line of products. Tulip is a well-established brand in re-usable cannulas currently used worldwide in many procedures such as Liposuction, Body Sculpting, Fat Transfer and more. Tulip has a history dating back to the early 1990’s when the name was used to describe the original cannulas used to connect to syringes for use in Liposuction and the introduction of the Syringe System now commonly used in related procedures.

Marc Pilkington, CEO, said “this decision is very important for CBSI because it links the new disposable products to a long established brand that is well known worldwide in the Plastic Surgery and Surgical Dermatology communities.” He continues by saying, “we have done a lot to bring this company forward since our shareholder meeting in February of this year in which the shareholders approved the new re-organization plan. We are on target both in funding and product development for the planned release of the first Plastic Surgery product line for first quarter 2006. We are very excited and moving towards building a professional, high caliber executive team in taking this great company forward to revenue.”

Cell Bio-Systems, Inc. (CBSI) is a Nevada corporation whose operations are based in San Diego, California. Founded in 2004, Cell Bio-Systems is a Medical Device, Biotechnology Company seeking to manufacture and distribute patented technologies for the Plastic & Cosmetic Surgery, Biopsy, Orthopedic Surgery, Stem Cell Therapy and other Living Tissue markets. Cell Bio-System’s is the exclusive licensee of patented syringe connection devices which use the worldwide recognized Tulip brand name. Cell Bio-Systems will manufacture, market, and distribute medical devices, adapted with these and other patented technologies, to physicians, clinics, military, health organizations, hospitals and other distribution outlets.

This press release contains certain forward-looking information about Cell Bio-Systems, Inc. ("Cell Bio-Systems") which is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "expect(s)," "feel(s)," "believe(s)," "will," "may," "anticipate(s)," and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of Cell Bio-Systems, Inc., that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: our lack of operating revenue and earnings history, our need for additional capital to pursue our business strategy, the grade and quantity of minerals in our projects may not be economic, we do not have fee title to our properties, but derive our right through leases and the Mining Law, we are a non-reporting company and as such do not make periodic filings with the Securities and Exchange Commission, we trade on the Pink Sheets and there can be no assurances that a liquid market will develop in our securities. Readers are cautioned not to place undue reliance on these forward-looking statements. Cell Bio-Systems does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information